On August 13, 2025, President Trump signed an executive order aimed at strengthening America’s pharmaceutical supply chains. Officially titled “Ensuring…
Read More →
On July 31, 2025, the United States Department of Justice (DOJ) announced a $9.8 million settlement with Illumina, Inc. (Illumina)…
Read More →
Abstract – This article examines the problem of fabricated or hallucinated citations in legal briefs, focusing on the recent federal…
Read More →
In Metacel Pharmaceuticals LLC v. Rubicon Research Private Ltd., the Court of Appeals for the Federal Circuit (CAFC) held that…
Read More →
The Health Resources and Services Administration (“HRSA”) plans to implement a limited pilot program that will allow approved manufacturers to…
Read More →
Recent reviews of genetic research continue to challenge long-held assumptions about the causes of malignant mesothelioma. While plaintiffs’ attorneys often…
Read More →
California’s Assembly Bill 489 (“AB 489”) signals more than just a tweak to existing healthcare law—it’s a glimpse into how…
Read More →
AI is no longer just a tool for tech giants. Every day, small and mid-sized companies are using AI for…
Read More →
On August 4, 2025, Illinois enacted the Wellness and Oversight for Psychological Resources Act (HB 1806) (the Act), imposing sweeping…
Read More →
On August 6, 2025, following a four-week trial, a jury in the Southern District of New York delivered a mixed…
Read More →